Items Tagged ‘Biogen’

March 29, 2019

Mayo Clinic in the News Weekly Highlights for March 29, 2019

By Emily Blahnik Emily Blahnik

Reuters, Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value by Julie Steenhuysen — Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer’s disease drug aducanumab, a major setback in the quest to find a treatment for the mind-wasting disease and a blow to Biogen, […]

View full entry

Tags: AliveCor, alzheimer's disease, anal cancer, artificial Intelligence, Biogen, blood donation, Blood Donor Program, caffeine, cognitive decline, dementia, depression, Derrick Rose


August 6, 2018

Mayo Clinic in the News Weekly Highlights for August 3, 2018

By Emily Blahnik Emily Blahnik

Washington Post, Hookworms burrowed into a teenager’s skin during a trip to Florida. You can’t unsee these images. by Lindsey Bever — There are two main types of hookworm: human hookworms and animal, or zoonotic, hookworms. Bobbi Pritt, director of the Clinical Parasitology Laboratory in the Mayo Clinic’s Department of Laboratory Medicine and Pathology, said […]

View full entry

Tags: Alan Alda, alzheimer's disease, Aneurysms, Biogen, birth control pills, blood cancer, breast cancer research, breastfeeding, Bryan Duncan, Cancer, CAR-T cell, diets


July 13, 2018

Mayo Clinic in the News Weekly Highlights for July 9, 2018

By Emily Blahnik Emily Blahnik

        Wall Street Journal, New Effort for Lyme Disease Vaccine Draws Early Fire by Sumathi Reddy — Gregory Poland, director of the vaccine research group at Mayo Clinic in Rochester, Minn., published a 2011 study in the journal Clinical Infectious Diseases detailing what happened with the previous Lyme vaccine and lessons learned […]

View full entry

Tags: age-related disease, alzheimer's disease, Angie Murad, artificial Intelligence, asthma exacerbation, Biogen, Career Immersion Program, cervical cancer, Darla Lytle, dementia, Diversity, Dr Felipe Sierra


Contact Us · Privacy Policy